- Letter
- Published:
Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene
- Hans W. D. Matthes1,
- Rafael Maldonado2,
- Frédéric Simonin1,
- Olga Valverde2,
- Susan Slowe3,
- Ian Kitchen3,
- Katia Befort1,
- Andrée Dierich4,
- Marianne Le Meur4,
- Pascal Dollé4,
- Eleni Tzavara5,
- Jacques Hanoune5,
- Bernard P. Roques2 &
- …
- Brigitte L. Kieffer1
Naturevolume 383, pages819–823 (1996)Cite this article
8110Accesses
1414Citations
193Altmetric
Abstract
DESPITE tremendous efforts in the search for safe, efficacious and non-addictive opioids for pain treatment, morphine remains the most valuable painkiller in contemporary medicine. Opioids exert their pharmacological actions through three opioid-receptor classes1,2, µ, δ and κ, whose genes have been cloned3. Genetic approaches are now available to delineate the contribution of each receptor in opioid functionin vivo. Here we disrupt the μ-opioid-receptor gene in mice by homologous recombination and find that there are no overt behavioural abnormalities or major compensatory changes within the opioid system in these animals. Investigation of the behavioural effects of morphine reveals that a lack of μ receptors abolishes the analgesic effect of morphine, as well as place-preference activity and physical dependence. We observed no behavioural responses related to δ- or κ-receptor activation with morphine, although these receptors are present and bind opioid ligands. We conclude that the µ-opioid-receptor gene product is the molecular target of morphinein vivo and that it is a mandatory component of the opioid system for morphine action.
This is a preview of subscription content,access via your institution
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Browstein, M.Proc. Natl Acad. Sci. USA90, 5391–5393 (1993).
Goldstein, A. & Naidu, A.Mol. Pharmacol.36, 265–272 (1989).
Kieffer, B. L.Cell. Mol. Neurobiol.15, 615–635 (1995).
Pasternak, G. W.Clin. Pharmacol.16, 1–18 (1993).
Rossier, J.Nature298, 221–222 (1982).
Cowan, A. inHandbook of Experimental Pharmacology Opioids II (ed. Herz, A.) Vol.104, 393–414 (Springer, Berlin, 1993).
Roques, B. P., Noble, F., Daugé, V., Fournié-Zaluski, M.-C. & Beaumont, A.Pharmacol. Rev.45, 87–146 (1993).
Baamonde, A., Daugé, V., Gacel, C. & Roques, B. P.J. Pharmacol. Exp. Ther.257, 767–773 (1991).
Dickenson, A. H.Br. Med. Bull.47, 690–702 (1991).
Gacel, G., Zajac, J. M., Delay-Goyet, P., Dauge, V. & Roques, B. P.J. Med. Chem.31, 374–383 (1988).
Di Chiara, G. & North, A.Trends Pharmacol. Sci.13, 185–193 (1992).
Koob, G. F.Trends Biochem. Sci.13, 177–184 (1992).
Katz, R. J. & Gormezano, G.Pharmacol. Biochem. Behav.11, 231–233 (1979).
Shippenberg, T. S., Bals-Kubik, R. & Herz, A.Brain Res.436, 234–239 (1987).
Terwillinger, R. Z., Beitner-Johnson, D., Sevarino, K. A., Crain, S. M. & Nestler, E. J.Brain Res.548, 100–110 (1991).
Maldonado, R., Negus, S. & Koob, G. F.Neuropharmacology31, 1231–1241 (1992).
Wei, E. T.J. Pharmacol. Exp. Ther.216, 12–18 (1981).
Cowan, A., Zhu, X. Z., Mosberg, H. I., Omnaas, J. R. & Porreca, F.J. Pharmacol. Exp. Ther.246, 950–955 (1988).
Traynor, J. R. & Elliot, J.Trends Pharmacol. Sci.14, 84–85 (1993).
Kieffer, B. L., Befort, K., Gavéeriaux-Ruff, R. C. & Hirth, C. G.Proc. Natl Acad. Sci USA89, 12048–12052 (1992).
McBurney, M. W.et al.Nucleic Acids Res.19, 5755–5761 (1991).
Lufkin, T., Dierich, A., LeMeur, M., Mark, M. & Chambon, P.Cell88, 1105–1119 (1991).
Ilien, B.et al.Biochem. Pharmacol.37, 3843–3851 (1988).
Kitchen, I.et al.J. Pharmacol. Exp. Ther.275, 1595–1607 (1995).
Décimo, D., Labouesse, G. & Dollé, P. inGene probes 2: A Practical Approach (eds Names, B. D. & Higgins, S.) 183–210 (Oxford Univ. Press, 1995).
Schmidt, C.et al.Eur. J. Pharmacol.192, 253–262 (1991).
Valverde, O., Fournier-Zaluski, M.-C., Roques, B. P. & Maldonado, R.Psychopharmacology123, 119–126 (1996).
Maldonado, R.et al.Science273, 657–650 (1996).
Hanoune, J., Stengel, D., Lacombe, M. L., Fledmann, G. & Coudrier, E.J. Biol. Chem.252, 2039–2045 (1977).
Author information
Authors and Affiliations
UPR 9050 CNRS, ESBS Université Louis Pasteur, 67400, Illkirch, Strasbourg, France
Hans W. D. Matthes, Frédéric Simonin, Katia Befort & Brigitte L. Kieffer
Département de Pharmacochimie Moléculaire et Structurale, INSERM U266. URA D1500 CNRS, Université René Descartes, 75270, Paris, France
Rafael Maldonado, Olga Valverde & Bernard P. Roques
Receptors and Cellular Regulation Research Group, School of Biological Sciences, University of Surrey, Guildford, Surrey, GU2 5XH, UK
Susan Slowe & Ian Kitchen
Institut de Génétique et Biologie Moléculaire et Cellulaire, BP 163, 67404, Illkirch, Strasbourg, France
Andrée Dierich, Marianne Le Meur & Pascal Dollé
Unité de Recherches INSERM U-99, Hôpital Henri Mondor, 94010, Créteil, France
Eleni Tzavara & Jacques Hanoune
- Hans W. D. Matthes
You can also search for this author inPubMed Google Scholar
- Rafael Maldonado
You can also search for this author inPubMed Google Scholar
- Frédéric Simonin
You can also search for this author inPubMed Google Scholar
- Olga Valverde
You can also search for this author inPubMed Google Scholar
- Susan Slowe
You can also search for this author inPubMed Google Scholar
- Ian Kitchen
You can also search for this author inPubMed Google Scholar
- Katia Befort
You can also search for this author inPubMed Google Scholar
- Andrée Dierich
You can also search for this author inPubMed Google Scholar
- Marianne Le Meur
You can also search for this author inPubMed Google Scholar
- Pascal Dollé
You can also search for this author inPubMed Google Scholar
- Eleni Tzavara
You can also search for this author inPubMed Google Scholar
- Jacques Hanoune
You can also search for this author inPubMed Google Scholar
- Bernard P. Roques
You can also search for this author inPubMed Google Scholar
- Brigitte L. Kieffer
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Matthes, H., Maldonado, R., Simonin, F.et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene.Nature383, 819–823 (1996). https://doi.org/10.1038/383819a0
Received:
Accepted:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
Distinct µ-opioid ensembles trigger positive and negative fentanyl reinforcement
- Fabrice Chaudun
- Laurena Python
- Christian Lüscher
Nature (2024)
Genetic mouse models in opioid research: current status and future directions
- Monserrat Avila-Zozaya
- Venetia Zachariou
Journal of Neural Transmission (2024)
Ventral tegmental area glutamate neurons establish a mu-opioid receptor gated circuit to mesolimbic dopamine neurons and regulate opioid-seeking behavior
- Dillon J. McGovern
- Abigail M. Polter
- David H. Root
Neuropsychopharmacology (2023)
Red hair and pain sensitivity: insights into genomics of pain?
- Hannah R. Williams
- Jaideep J. Pandit
Anesthesiology and Perioperative Science (2023)
Targeting Peripheral μ-opioid Receptors or μ-opioid Receptor-Expressing Neurons Does not Prevent Morphine-induced Mechanical Allodynia and Anti-allodynic Tolerance
- Feng Du
- Guangjuan Yin
- Longzhen Cheng
Neuroscience Bulletin (2023)